Who owns Adverum Biotechnologies?
- CUSIP Number: 00773u108
Tip: Access positions for across all investors
Analyze quarterly positions in Adverum Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Adverum Biotechnologies stock
Who bought or sold Adverum Biotechnologies this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Commodore Capital | 10M | $7.5M | 0% | Dec 2023 |
|
VR Adviser | 5.1M | $3.9M | -22% | Dec 2023 |
|
Versant Venture Management | 5.1M | $3.8M | 0% | Dec 2023 |
|
BML Capital Management | 4.6M | $3.4M | 16% | Dec 2023 |
|
Goldman Sachs Group | 4.6M | $3.4M | 0% | Dec 2023 |
|
Bank of America Corporation | 4.3M | $3.2M | -10% | Dec 2023 |
|
Vanguard Group | 4.2M | $3.2M | 0% | Dec 2023 |
|
AIGH Capital Management | 3.2M | $2.4M | 140% | Dec 2023 |
|
Newtyn Management | 823k | $620k | -20% | Dec 2023 |
|
Worth Venture Partners | 784k | $591k | 136% | Dec 2023 |
|
Two Sigma Advisers | 462k | $348k | -6% | Dec 2023 |
|
Two Sigma Investments | 446k | $336k | -14% | Dec 2023 |
|
Soleus Capital Management | 425k | $320k | 100% | Dec 2023 |
|
Millennium Management | 298k | $224k | 114% | Dec 2023 |
|
Acuitas Investments | 291k | $219k | 0% | Dec 2023 |
|
Dimensional Fund Advisors | 189k | $142k | -36% | Dec 2023 |
|
Cantor Fitzgerald, L. P. | 158k | $119k | -1% | Dec 2023 |
|
Advisor Group Holdings | 101k | $76k | 12% | Dec 2023 |
|
Monaco Asset Management SAM | 79k | $60k | 34% | Dec 2023 |
|
Marquette Asset Management | 60k | $45k | 0% | Dec 2023 |
|
Mariner Wealth Advisors | 50k | $38k | 0% | Dec 2023 |
|
Squarepoint Ops | 42k | $32k | 100% | Dec 2023 |
|
Bank of New York Mellon | 40k | $30k | -42% | Dec 2023 |
|
Citadel Advisors | 37k | $28k | 132% | Dec 2023 |
|
Charles Schwab Investment Management | 36k | $27k | 0% | Dec 2023 |
|
Lipe & Dalton | 15k | $11k | 0% | Dec 2023 |
|
IPG Investment Advisors | 10k | $7.5k | 100% | Dec 2023 |
|
Nwam | 10k | $7.5k | 0% | Dec 2023 |
|
Lazard Asset Management | 9.9k | $0 | -5% | Dec 2023 |
|
Rhumbline Advisers | 2.9k | $2.2k | 0% | Dec 2023 |
|
Simplex Trading | 2.3k | $999.999000 | 100% | Dec 2023 |
|
Wells Fargo & Company | 976.00 | $734.928000 | -50% | Dec 2023 |
|
UBS Group | 815.00 | $614.021000 | 2% | Dec 2023 |
|
Parallel Advisors | 500.00 | $376.000000 | -50% | Dec 2023 |
|
Jpmorgan Chase & Co | 405.00 | $305.005500 | 0% | Dec 2023 |
|
GHP Investment Advisors | 200.00 | $151.000000 | 0% | Dec 2023 |
|
Royal Bank of Canada | 62.00 | $0 | 44% | Dec 2023 |
|
Hanson McClain Advisors | 20.00 | $16.000000 | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 18.00 | $14.000400 | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 3.00 | $2.000100 | 0% | Dec 2023 |
|
Who sold out of Adverum Biotechnologies?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citigroup | Sep 2023 | 477k | $715k |
Marshall Wace | Sep 2023 | 237k | $356k |
Apexium Financial | Dec 2023 | 60k | $45k |
Man Group | Sep 2023 | 35k | $53k |
Jane Street | Sep 2023 | 34k | $51k |
Hrt Financial | Sep 2023 | 25k | $37k |
Captrust Financial Advisors | Sep 2023 | 21k | $31k |
Cubist Systematic Strategies | Sep 2023 | 20k | $30k |
Wolverine Trading | Sep 2023 | 20k | $30k |
Russell Investments | Sep 2023 | 16k | $24k |
Ausdal Financial Partners | Dec 2023 | 10k | $7.5k |
Ronald Blue Trust | Sep 2023 | 1.5k | $2.0k |
Sound Income Strategies | Dec 2023 | 10.00 | $8.000000 |